Posts by: Stacy Grieve, PhD

News

Preliminary data from a Phase 1/2 trial, presented at the American Society of Clinical Oncology Annual 2017 Annual Meeting, shows that Opdivo (nivolumab) monotherapy was effective in more than 26 ... Read more

January 6, 2017January 6, 2017

Gene Variants Help to Explain Susceptibility to Cervical and Other HPV-positive Cancers

News

Different gene variants, also referred to as single nucleotide polymorphisms (SNPs), can affect susceptibility to cancer. A recent study has uncovered the molecular mechanism underlying why patients with a specific ... Read more

December 19, 2016

Specific Gene Emerges as Potential Cervical Cancer Prognostic Marker, Therapeutic Target

News

A study assessing genetic variations in cervical cancer tissues identified the gene CLDN1 (Claudin 1 protein) as playing a significant role in cervical cancer progression through its ability to promote ... Read more

December 12, 2016December 12, 2016

Low Cervical Cancer Screening Rates in Older Chinese Women Mainly Due to Lack of Prevention Education

News

Although age is a major risk factor for cervical cancer — especially between the late teens and mid-30s — a new study shows that Chinese women age 50 and older ... Read more